Category:

Regulatory

Award, fellowship & grant

Business and Market Strategy

Regulatory

Lupin Receives U.S. FDA Approval for Interchangeable Ranibizumab Biosimilar Ranluspec

Regulatory

FDA Launches One-Day Inspection Pilot to Enhance Risk-Based Oversight

Regulatory

FDA Novel Drug Approvals 2026 Q1: Full List & Insights

book/virender-singh-molecules-mentors-mindsets/

Regulatory

FDA Grants Full Approval to Tecartus CAR-T Therapy for Mantle Cell Lymphoma

Regulatory

FDA Approves drug for Neurologic Symptoms of Hunter Syndrome

Regulatory

FDA Approves Kresladi: First Gene Therapy for Rare Immune Disorder LAD-I

Regulatory

CDSCO Flags 4 Spurious Drugs and 194 Substandard Medicines in February 2026

Regulatory

Immunogenicity Risk Assessment Drives Smarter and Safer Drug Development | EpiVax

Regulatory

FDA Draft Guidance on NAMs Shifts Focus to Validation in Drug Development

Regulatory

FDA Novel Drug Therapy Approvals for 2025 | Quarter 4

Regulatory

FDA Approves New Gene Therapy for Spinal Muscular Atrophy (SMA)

Regulatory

Accord BioPharma Announces FDA Approval of Denosumab Biosimilars

book/virender-singh-molecules-mentors-mindsets/

IIT Gandhinagar Hosts Workshop on Urban Resilience and Climate-Resilient Cities

June 25, 2026

AI Study of 21,000+ Indians Reveals Only 2.3% Have “Perfect Skin”

June 25, 2026

Salt-Inducible Kinase: A novel drug target for immunotherapy of Ovarian Cancer

June 24, 2026

Coherus and Zumutor Launch Phase 1 Trial of ZM008 and LOQTORZI Combination Therapy

June 24, 2026

IIT Gandhinagar Joins India–France Initiative to Boost Research and Innovation

June 24, 2026